ArticleMolecular medicine (Cambridge, Mass.)2026

Low-PSMA hormone-sensitive prostate cancer: a distinct clinical and molecular state.

Haotian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.